Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Standard BioTools Inc.

Standard BioTools Inc. (FLDM) Stock Overview

Explore Standard BioTools Inc.’s financial performance, market position, analyst ratings, and future outlook.

FLDM●NASDAQ
HealthcareMedical - Diagnostics & Research
$3.71
$0.28(7.02%)
U.S. Market opens in 12h 46m

Standard BioTools Inc. (FLDM)

Meyka AI Score

Z

Key Financials

Market Cap294.2M
P/E Ratio18.55
EPS (TTM)$-0.78
ROE0.17%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

FLDM Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Standard BioTools Inc. (NASDAQ: FLDM) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Standard BioTools Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of FLDM on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $N/A for the NASDAQ listing.

Key metrics behind Standard BioTools Inc.'s NASDAQ-traded stock include a P/E ratio of 18.55 and a market capitalization of 294.2M. Combined with our AI analysis, these give both institutional and retail investors a clear view of FLDM on the NASDAQ.

Price Performance (NASDAQ: FLDM)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
5.70%
3-Year Change
6.92%
5-Year Change
-45.76%
All-Time (Max) Change
-73.54%

Contact Information

https://www.standardbio.com
16502666000
7000 Shoreline Ct Ste 100, South San Francisco, CA, 94080

Company Facts

6,150 Employees
IPO DateFeb 10, 2011
CountryUS

Frequently Asked Questions